RECTAL CANCER, ADENOCARCINOMA
Clinical trials for RECTAL CANCER, ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER, ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL CANCER, ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boosts cancer treatment? new trial tests Probio-M9 in rectal cancer
Disease control Recruiting nowThis study tests whether adding a probiotic called Probio-M9 to standard chemoradiation and immunotherapy (tislelizumab) can help shrink rectal tumors before surgery. About 50 adults with locally advanced rectal cancer will be randomly assigned to receive the probiotic or a place…
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New combo therapy could help some rectal cancer patients skip surgery
Disease control Recruiting nowThis study is for people with newly diagnosed, high-risk rectal cancer. It tests a treatment plan given before surgery that includes a short course of radiation followed by a mix of chemotherapy and immunotherapy. The goal is to shrink or eliminate the tumor so much that some pat…
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for advanced colorectal cancer: drug cocktail shows promise
Disease control Recruiting nowThis study is testing a combination of three drugs (trastuzumab-deruxtecan, capecitabine, and bevacizumab) as a first treatment for people with a specific type of advanced colorectal cancer that has spread (HER-2 positive). The goal is to see how well this drug combo shrinks tumo…
Matched conditions: RECTAL CANCER, ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated May 07, 2026 18:40 UTC